View in EDS

Cellular and humoral responses to an HIV DNA prime by electroporation boosted with recombinant vesicular stomatitis virus expressing HIV subtype C Env in a randomized controlled clinical trial.

Saved in:
Bibliographic Details
Title: Cellular and humoral responses to an HIV DNA prime by electroporation boosted with recombinant vesicular stomatitis virus expressing HIV subtype C Env in a randomized controlled clinical trial.
Authors: Wilson GJ; Vanderbilt University Medical Center, Nashville, TN, United States., Rodriguez B; Case Western Reserve University, Cleveland, OH, United States., Li SS; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, United States., Allen M; DAIDS/NIAID/NIH, Rockville, MD, United States., Frank I; University of Pennsylvania, Philadelphia, PA, United States., Rudnicki E; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, United States., Trahey M; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, United States., Kalams S; Vanderbilt University Medical Center, Nashville, TN, United States., Hannaman D; Ichor Medical Systems, San Diego, CA, United States., Clarke DK; Auro Vaccines LLC (formerly Profectus Biosciences, Inc.), Pearl River, NY, United States., Xu R; Auro Vaccines LLC (formerly Profectus Biosciences, Inc.), Pearl River, NY, United States., Egan M; Auro Vaccines LLC (formerly Profectus Biosciences, Inc.), Pearl River, NY, United States., Eldridge J; Auro Vaccines LLC (formerly Profectus Biosciences, Inc.), Pearl River, NY, United States., Pensiero M; DAIDS/NIAID/NIH, Rockville, MD, United States., Latham T; Auro Vaccines LLC (formerly Profectus Biosciences, Inc.), Pearl River, NY, United States., Ferrari G; Department of Surgery, Duke University, Durham, NC, United States., Montefiori DC; Department of Surgery, Duke University, Durham, NC, United States., Tomaras GD; Department of Surgery, Duke University, Durham, NC, United States., De Rosa SC; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, United States., Jacobson JM; Case Western Reserve University, Cleveland, OH, United States., Miner MD; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, United States., Elizaga M; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, United States.
Corporate Authors: HIV Vaccine Trials Network 112 Protocol Team
Source: Vaccine [Vaccine] 2023 Apr 17; Vol. 41 (16), pp. 2696-2706. Date of Electronic Publication: 2023 Mar 17.
Publication Type: Randomized Controlled Trial; Journal Article; Research Support, N.I.H., Extramural
Journal Info: Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2518 (Electronic) Linking ISSN: 0264410X NLM ISO Abbreviation: Vaccine Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1873-2518
DOI:10.1016/j.vaccine.2023.03.015